scholarly journals Gastric Signet Ring Cell Carcinoma: A Comparative Analysis of Clinicopathologic Features

2020 ◽  
Vol 27 (1) ◽  
pp. 107327482097659
Author(s):  
Boubacar Efared ◽  
Mohamed Kadi ◽  
Laila Tahiri ◽  
Nada Lahmidani ◽  
Karim Ibn Majdoub Hassani ◽  
...  

Signet ring cell carcinoma (SRC) is a distinct histological subtype of gastric carcinoma. Our aim is to investigate differential characteristics between gastric SRC and other non SRC carcinomas (nSRC). It was a retrospective study including 183 patients diagnosed with gastric carcinoma over a period of 5 years at our pathology department. We performed statistical comparison of clinicopathological features between patients with SRC and those with nSRC. 127 patients (69.4%) had nSRC, 56 had SRC (30.6%), the mean age was 56.67 ± 14.03 years. Patients with SRC were younger than those with nSRC (mean age of 49.66 versus 59.76, P = 0.030). Patients with SRC tend to have more diffuse tumors in the stomach ( P = 0.005), with flat macroscopic appearance ( P = 0.001). Patients with SRC present more often with pT3 tumors ( P < 0.001), lymph node metastasis ( P = 0.024) and perineural invasion ( P = 0.003). There were no significant differences between SRC and nSRC in gender, vascular invasion or distant metastasis ( P > 0.05). The median survival time was 42.82 ± 1.70 months. Patients with nSRC live longer than those with SRC, but the difference was not significant ( P = 0.28). SRC is a histological subtype of gastric carcinoma with distinctive clinicopathologic features. The clinical management of patients should take into account these particular features.

2006 ◽  
Vol 39 (1) ◽  
pp. 16-22 ◽  
Author(s):  
Tomoki Makino ◽  
Hideyuki Mishima ◽  
Masakazu Ikenaga ◽  
Toshimasa Tsujinaka ◽  
Masashi Takeda ◽  
...  

2005 ◽  
Vol 66 (12) ◽  
pp. 2915-2920 ◽  
Author(s):  
Junichi GOTOH ◽  
Kengo KITA ◽  
Masato FUJIYOSHI ◽  
Gentaro HIROKATA ◽  
Koji IMAI ◽  
...  

2021 ◽  
pp. 165-172
Author(s):  
Héctor Hugo Buerba-Vieregge ◽  
Ricardo Fernández-Ferreira ◽  
Pamela Denisse Soberanis-Piña ◽  
Ildefonso Roberto De la Peña-López ◽  
Lilian Mónica Navarro-García ◽  
...  

Breast metastasis from gastric signet ring cell carcinoma is extremely rare in clinical practice. The estimated incidence is 0.5–1.3%. There are few cases reported in the literature (approx. less than 60) of breast metastasis from gastric signet ring cell carcinoma, and due to the rare association between gastric cancer and its extension to the breast, it is difficult to establish the diagnosis. Clinical history, histological findings, and immunohistochemical markers are helpful in distinguishing primary breast cancer from breast metastasis of gastric cancer. The treatment for breast metastasis from gastric carcinoma remains controversial. The prognosis of breast metastasis from gastric carcinoma is generally poor. We report a case of breast metastasis of gastric signet ring cell carcinoma in a 38-year-old woman. She started chemotherapy with ramucirumab, paclitaxel, and irinotecan. Three months later, a combined 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography showed a complete response. This is the first reported case of breast metastasis from gastric signet ring cell carcinoma with a complete response.


2006 ◽  
Vol 30 (6) ◽  
pp. 880-884 ◽  
Author(s):  
Jei Hee Lee ◽  
Mi-Suk Park ◽  
Ki Whang Kim ◽  
Jeong-Sik Yu ◽  
Myeong-Jin Kim ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document